Floatz logo

Maraviroc

Hematopoietic Stem Cell Transplantation

Affiliated Hospital to Academy of Military Medical SciencesSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

75 Active assets in the Hematopoietic Stem Cell Transplantation cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
The First Affiliated Hospital of Soochow University
Phase 3BBB
Busulphan
Institute of Hematology & Blood Diseases Hospital, China
Phase 3BBB
FILGRASTIM
National Cancer Institute (NCI)
Phase 2/3BBB
Decitabine
Chinese PLA General Hospital
Phase 4BBB
Cyclophosphamide
St. Jude Children's Research Hospital
Phase 3BBB

View all 50 →

Same molecule, other indications

Maraviroc is also rated in:

HIV infectious diseaseDormant
B
Indicative ·
62 / 100
View asset →
chronic myeloid leukemiaDormant
B
Indicative ·
57 / 100
View asset →
myelodysplastic syndromeDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →